Washington D.C., Oct 25, 2004 / 22:00 pm
The United States Conference of Catholic Bishops (USCCB) launched a nationwide two-week ad campaign on stem-cell research today.
The ads, aimed at explaining the distinction between embryonic stem-cell research and adult stem-cell research, will appear in the New York Times, USA Today, the Washington Times, the National Catholic Reporter and diocesan publications.
The campaign message is that science does not have to kill in order to cure.
Cathy Cleaver Ruse, Esq., director of Planning and Information for the USCCB's Secretariat for Pro-Life Activities, explains that embryonic stem-cell research requires the destruction of human life at the embryonic stage.
"Adult stem-cell research is already helping people with many diseases, including heart disease, spinal cord injury, even Parkinson's disease," she said, unlike embryonic stem-cell research that “comes with a hefty price tag: the deliberate destruction of human life.”
The USCCB had also put out an an informational flyer, "Stem Cell Research and Human Cloning: Questions and Answers."
To view the ad, go to: http://www.usccb.org/prolife/stemcellads.htm. To view the flyer, go to: http://www.usccb.org/prolife/stemcellQ&A.pdf.
Subscribe to our daily newsletter
At Catholic News Agency, our team is committed to reporting the truth with courage, integrity, and fidelity to our faith. We provide news about the Church and the world, as seen through the teachings of the Catholic Church. When you subscribe to the CNA UPDATE, we'll send you a daily email with links to the news you need and, occasionally, breaking news.
As part of this free service you may receive occasional offers from us at EWTN News and EWTN. We won't rent or sell your information, and you can unsubscribe at any time.
Click hereOur mission is the truth. Join us!
Your monthly donation will help our team continue reporting the truth, with fairness, integrity, and fidelity to Jesus Christ and his Church.
Donate to CNA